A review of various types of male contraception

Birth control options for men are limited to only condoms and vasectomies. This review focuses on various types of male contraceptives for adequate fertility control and family planning by mutual understanding of couples (healthy family planning). Male contraceptive methods include hormonal and non-hormonal contraceptives, condoms, vasectomies, and using active ingredients from plants. Contraception in men is related to progesterone concentration, sperm count, sperm motility, sperm maturation and sperm viability. Studies are required on no side-effect-safe contraceptives for men that control serum progesterone levels, however do not increase oxidative stress. In conclusion, this article covers hormonal, non-hormonal, and plant-based male contraception in addition to the popular condoms and vasectomy. Furthermore, it includes partial description of the variety and mechanisms of male contraceptive methods available to men.

Contraception; Male contraceptive method; Birth control; Progesterone

[1] Gladys MM, Joyce CA. Sexual activity and contraceptive use among teenagers aged 15–19 in the United States, 2015–2017. NCHS Data Brief. 2020; 366: 1–8.

[2] Nickels L, Yan W. Nonhormonal male contraceptive development—strategies for progress. Pharmacological Reviews. 2024; 76: 37–48.

[3] Bearak J, Popinchalk A, Ganatra B, Moller AB, Tunçalp O, Beavin C, et al. Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990–2019. The Lancet Global Health. 2020; 8: e1152–e1161.

[4] Kimport K, Rasidjan MP. Exploring the emotional costs of abortion travel in the United States due to legal restriction. Contraception. 2023; 120: 109956.

[5] Page ST, Blithe D, Wang C. Hormonal male contraception: getting to market. Frontiers in Endocrinology. 2022; 13: 891589.

[6] Alspaugh A, Barroso J, Reibel M, Phillips S. Women’s contraceptive perceptions, beliefs, and attitudes: an integrative review of qualitative research. Journal of Midwifery & Women’s Health. 2020; 65: 64–84.

[7] Thirumalai A, Page ST. Recent developments in male contraception. Drugs. 2019; 79: 11–20.

[8] Bearak J, Popinchalk A, Ganatra B, Moller AB, Tunçalp Ö, Beavin C, et al. Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990–2019. The Lancet Global Health. 2020; 8: e1152–e1161.

[9] Nieschlag E, Nieschlag S. Why we need more methods for male contraception. Andrology. 2023; 11: 421–424.

[10] Faix A, Methorst C, Hupertan V, Huyghe E. Male contraception. Progress in Urology. 2023; 33: 718–732. (In French)

[11] Lue Y, Wang C, Lydon JP, Leung A, Li J, Swerdloff RS. Functional role of progestin and the progesterone receptor in the suppression of spermatogenesis in rodents. Andrology. 2013; 1: 308–317.

[12] Abbe CR, Page ST, Thirumalai A. Male contraception. Yale Journal of Biology and Medicine. 2020; 93: 603–613.

[13] Caroppo E. Male hypothalamic–pituitary–gonadal axis. In Lipshultz LI, Howards SS, Niederberger CS (eds.) Infertility in the Male (pp. 14–28). Cambridge University Press. Cambridge University Press: UK. 2009.

[14] Louwagie EJ, Quinn GFL, Pond KL, Hansen KA. Male contraception: narrative review of ongoing research. Basic and Clinical Andrology. 2023; 33: 30.

[15] Thirumalai A, Page ST. Androgens in male contraception. Best Practice & Research Clinical Endocrinology & Metabolism. 2022; 36: 101627.

[16] Thirumalai A, Amory JK. Emerging approaches to male contraception. Fertility and Sterility. 2021; 115: 1369–1376.

[17] Wang C, Festin MP, Swerdloff RS. Male hormonal contraception: where are we now? Current Opinion in Obstetrics and Gynecology. 2016; 5: 38–47.

[18] Thirumalai A, Page ST. Male hormonal contraception. Annual Review of Medicine. 2020; 71: 17–31.

[19] McNeil RT, Ekwere E. Ricinus communis-linn (castor plant), male contraceptives and reproductive health of women. African Journal of Reproductive Health. 2021; 25: 135–141.

[20] Dominiak Z, Huras H, Kręcisz P, Krzeszowski W, Szymański P, Czarnecka K. Promising results in development of male contraception. Bioorganic & Medicinal Chemistry Letters. 2021; 41: 128005–128010.

[21] Nguyen BT, Yuen F, Farrant M, Thirumalai A, Fernando F, Amory JK, et al. Acceptability of the oral hormonal male contraceptive prototype, 11β-methyl-19-nortestosterone dodecylcarbonate (11β-MNTDC), in a 28-day placebo-controlled trial. Contraception. 2021; 104: 531–537.

[22] Wu S, Yuen F, Swerdloff RS, Pak Y, Thirumalai A, Liu PY, et al. Safety and pharmacokinetics of single-dose novel oral androgen 11β-methyl-19-nortestosterone-17β-Dodecylcarbonate in men. The Journal of Clinical Endocrinology & Metabolism. 2019; 104: 629–638.

[23] Yuen F, Thirumalai A, Pham C, Swerdloff RS, Anawalt BD, Liu PY, et al. Daily oral administration of the novel androgen 11β-MNTDC markedly suppresses serum gonadotropins in healthy men. The Journal of Clinical Endocrinology & Metabolism. 2020; 105: e835–e847.

[24] Ilani N, Liu PY, Swerdloff RS, Wang C. Does ethnicity matter in male hormonal contraceptive efficacy? Asian Journal of Andrology. 2011; 13: 579–584.

[25] Behre HM, Zitzmann M, Anderson RA, Handelsman DJ, Lestari SW, McLachlan RI, et al. Efficacy and safety of an injectable combination hormonal contraceptive for men. The Journal of Clinical Endocrinology & Metabolism. 2016; 101: 4779–4788.

[26] Thirumalai A, Amory JK. Emerging approaches to male contraception. Fertility and Sterility. 2021; 115: 1369–1376.

[27] Logan N, Wei Y. Nonhormonal male contraceptive development-strategies for progress. Pharmacological Reviews. 2023; 76: 37–48.

[28] O’Rand MG, Hamil KG, Adevai T, Zelinski M. Inhibition of sperm motility in male macaques with EP055, a potential non-hormonal male contraceptive. PLOS ONE. 2018; 13: e0195953.

[29] Salicioni AM, Gervasi MG, Sosnik J, Tourzani DA, Nayyab S, Caraballo DA, et al. Testis-specific serine kinase protein family in male fertility and as targets for non-hormonal male contraception†. Biology of Reproduction. 2020; 103: 264–274.

[30] Carlson EJ, Francis R, Liu Y, Li P, Lyon M, Santi CM, et al. Discovery and characterization of multiple classes of human CatSper blockers. ChemMedChem. 2022; 17: e202000499.

[31] Long JE, Lee MS, Blithe DL. Male contraceptive development: update on novel hormonal and nonhormonal methods. Clinical Chemistry. 2019; 65: 153–160.

[32] Chang Z, Qin W, Zheng H, Schegg K, Han L, Liu X, et al. Triptonide is a reversible non-hormonal male contraceptive agent in mice and non-human primates. Nature Communications. 2021; 12: 1253.

[33] Mariani NAP, Silva JV, Fardilha M, Silva EJR. Advances in non-hormonal male contraception targeting sperm motility. Human Reproduction Update. 2023; 29: 545–569.

[34] Beksinska M, Wong R, Smit J. Male and female condoms: their key role in pregnancy and STI/HIV prevention. Best Practice & Research Clinical Obstetrics & Gynaecology. 2020; 66: 55–67.

[35] Chen Y, Zhu JY, Hong KH, Mikles DC, Georg GI, Goldstein AS, et al. Structural basis of ALDH1A2 inhibition by irreversible and reversible small molecule inhibitors. ACS Chemical Biology. 2018; 13: 582–590.

[36] Noman MAA, Kyzer JL, Chung SSW, Wolgemuth DJ, Georg GI. Retinoic acid receptor antagonists for male contraception: current status†. Biology of Reproduction. 2020; 103: 390–399.

[37] Wisniewski A, Georg GI. BET proteins: investigating BRDT as a potential target for male contraception. Bioorganic & Medicinal Chemistry Letters. 2020; 30: 126958.

[38] Ayoub AM, Hawk LML, Herzig RJ, Jiang J, Wisniewski AJ, Gee CT, et al. BET bromodomain inhibitors with one-step synthesis discovered from virtual screen. Journal of Medicinal Chemistry. 2017; 60: 4805–4817.

[39] Law RP, Atkinson SJ, Bamborough P, Chung C, Demont EH, Gordon LJ, et al. Discovery of tetrahydroquinoxalines as bromodomain and extra-terminal domain (BET) inhibitors with selectivity for the second bromodomain. Journal of Medicinal Chemistry. 2018; 61: 4317–4334.

[40] D’Francisco F, Merlo ML, Vercellini R, Blanco P, Barbeito C, Gobello C. Effect of the indenopyridine RTI-4587-073 (l) on feline testicle. Animal Reproduction Science. 2019; 205: 10–17.

[41] Tcherdukian J, Mieusset R, Netter A, Lechevallier E, Bretelle F, Perrin J. Knowledge, professional attitudes, and training among health professionals regarding male contraceptive methods. The European Journal of Contraception & Reproductive Health Care. 2022; 27: 397–402.

[42] Copen CE. Condom use during sexual intercourse among women and men aged 15–44 in the United States: 2011–2015 national survey of family growth. National Health Statistics Reports. 2017; 105: 1–18.

[43] Giannou FK, Tsiara CG, Nikolopoulos GK, Talias M, Benetou V, Kantzanou M, et al. Condom effectiveness in reducing heterosexual HIV transmission: a systematic review and meta-analysis of studies on HIV serodiscordant couples. Expert Review of Pharmacoeconomics and Outcomes Research. 2016; 16: 489–499.

[44] Sundaram A, Vaughan B, Kost K, Bankole A, Finer L, Singh S, et al. Contraceptive failure in the United States: estimates from the 2006–2010 national survey of family growth. Perspectives on Sexual and Reproductive Health. 2017; 49: 7–16.

[45] Gallo MF, Grimes DA, Lopez LM, Schulz KF. Non-latex versus latex male condoms for contraception. Cochrane Database of Systematic Reviews. 2006; 1: CD003550.

[46] Wang C, Swerdloff RS. Approaches to contraceptive methods for men. 2002. Available at: https://doi.org/10.1093/acrefore/9780190632366.013.371 (Accessed: 28 February 2024).

[47] Wainipitapong S, Wiwattarangkul T, Bumphenkiatikul T. Delayed ejaculation due to improper male condom size: a case report. Sexual Medicine. 2021; 9: 100373.

[48] Abdel-Hamid IA, Ali OI. Delayed ejaculation: pathophysiology, diagnosis, and treatment. World Journal of Men’s Health. 2018; 36: 22–40.

[49] Drobner J, Fu MZ, Kaldany A, Velez-Leitner D. Historical review of the vasectomy: antiquated beliefs, novel techniques, and contemporary challenges. Urology. 2023; 182: 1–4.

[50] Kreutzig-Langenfeld T, Lellig E, Hinz P, Zilg F. Vasectomy: current information. Urologe A. 2021; 60: 523–532. (In German)

[51] Labrecque M, Dufresne C, Barone MA, St-Hilaire K. Vasectomy surgical techniques: a systematic review. BMC Medicine. 2004; 2: 21.

[52] Nutt M, Reed Z, Köhler TS. Vasectomy and prostate cancer risk: a historical synopsis of undulating false causality. Research and Reports in Urology. 2016; 8: 85–93.

[53] Boehm K, Valdivieso R, Meskawi M, Larcher A, Schiffmann J, Sun M, et al. Prostatitis, other genitourinary infections and prostate cancer: results from a population-based case—control study. World Journal of Urology. 2016; 34: 425–430.

[54] Suarez Arbelaez MC, Israeli JM, Tipton CD, Loloi J, Deebel N, Leong JY, et al. Pilot study: next-generation sequencing of the semen microbiome in vasectomized versus nonvasectomized men. European Urology Focus. 2023; 9: 75–82.

[55] Ghirelli-Filho M, Marchi PL, Mafra FA, Cavalcanti V, Christofolini DM, Barbosa CP, et al. Incidence of Y-chromosome microdeletions in children whose fathers underwent vasectomy reversal or in vitro fertilization with epididymal sperm aspiration: a case-control study. Einstein. 2016; 14: 534–540.

[56] Pant PR, Sharma J, Subba S. Scrotal haematoma: the most common complication of no-scalpel vasectomy. Kathmandu University Medical Journal. 2007; 5: 27–280.

[57] Doroftei B, Ilie OD, Maftei R, Scripcariu IS, Armeanu T, Stoian IL, et al. A narrative review discussing vasectomy-related impact upon the status of oxidative stress and inflammation biomarkers and semen microbiota. Journal of Clinical Medicine. 2023; 12: 2671.

[58] Sancak T, Kosal V, Okulmus C. Effect of castration and vasectomy on some oxidative stress parameters and blood hormone levels in rats. Brazilian Archives of Veterinary Medicine and Animal Science. 2023; 75: 651–656.

[59] Yang F, Li J, Dong L, Tan K, Huang X, Zhang P, et al. Review of vasectomy complications and safety concerns. World Journal of Men’s Health. 2021; 39: 406–418.

[60] Özcinar E, Canillioglu YE, Çetinel S. Histochemical examination of changes in testis after vasectomy in rats and qualitative analysis of tissue zinc content. To be published in bioRχiv. 2022. [Preprint].

[61] Park H, Kim K. Trends and factors associated with oral contraceptive use among Korean women. Healthcare. 2021; 9: 1386.

[62] Nelson OE, Simeon GG, Borobuebi OJ, Wankasi MEM, Chukwuma EF. Garlic extract reverses ischemic heart disease in female rats exposed to combined oral contraceptive pills. International Journal of Cardiovascular Sciences. 2024; 37: e20230060.

[63] David M, Ain QU, Jahan S, Ahmad M, Shah Q, Afsar T, et al. Determination of possible contraceptive potential of methanolic leaf extract of Mentha longifolia L. in adult male rats: a biochemical and histological study. Toxicology Research. 2022; 11: 951–961.

[64] Eise NT, Simpson JS, Thompson PE, Ventura S. Aqueous extracts of Urtica dioica (stinging nettle) leaf contain a P2-purinoceptor antagonist-Implications for male fertility. PLOS ONE. 2022; 17: e0271735.

[65] Oluyemi KA, Omotuyi IO, Jimoh OR, Adesanya OA, Saalu CL, Josiah SJ. Erythropoietic and anti-obesity effects of Garcinia cambogia (bitter kola) in Wistar rats. Biotechnology and Applied Biochemistry. 2007; 46: 69–72.

[66] Ghosh A, Pakhira BP, Tripathy A, Ghosh D. Male contraceptive efficacy of poly herbal formulation, contracept-TM, composed of aqueous extracts of Terminalia chebula fruit and Musa balbisiana seed in rat. Pharmaceutical Biology. 2017; 55: 2035–2042.

[67] Irais CM, Claudia BR, David PE, Ashutosh S, Rubén GG, Agustina RM, et al. Leaf and fruit methanolic extracts of Azadirachta indica exhibit antifertility activity on rats’ sperm quality and testicular histology. Current Pharmaceutical Biotechnology. 2021; 22: 400–407.

[68] Ain QU, David M, Ijaz MU, Jahan S. Assessment of antiandrogenic and antispermatogenic activity of Hedera nepalensis in adult male rats. Andrologia. 2022; 54: e14353.

[69] Shunnarah A, Tumlinson R, Calderón AI. Natural products with potential for nonhormonal male contraception. Journal of Natural Products. 2021; 84: 2762–2774.

[70] Lee MS, Bunin DI, Furimsky AM, Nguyen D, Parman T, Kim K, et al. Novel progestogenic androgens for male contraception: design, synthesis, and activity of C7 α-substituted testosterone. Biology of Reproduction. 2023; 109: 851–863.

[71] Wang L, Li L, Wu X, Wong CKC, Perrotta A, Silvestrini B, et al. MTORC1/rpS6 and p-FAK-Y407 signaling regulate spermatogenesis: insights from studies of the adjudin pharmaceutical/toxicant model. Seminars in Cell & Developmental Biology. 2022; 121: 53–62.

[72] Sidhom K, Panchendrabose K, Mann U, Patel P. An update on male infertility and intratesticular testosterone-insight into novel serum biomarkers. International Journal of Impotence Research. 2022; 34: 673–678.

[73] van Winden LJ, van Rossum HH. Testosterone analysis in prostate cancer patients. Advances in Clinical Chemistry. 2022; 108: 73–104.

[74] Verma S, Yadav A. Rising trends towards the development of oral herbal male contraceptive: an insight review. Future Journal of Pharmaceutical Sciences. 2021; 7: 1–15.

[75] Kent K, Johnston M, Strump N, Garcia TX. Toward development of the male pill: a decade of potential non-hormonal contraceptive targets. Frontiers in Cell and Developmental Biology. 2020; 8: 61.